Skip to main content

Scripps Research ranks third in 2026 Cure Innovation Index

April 29, 2026

Press Release Institute News

Cure Innovation Index—Institution Density Key Credit: Cure Experience Services, LLC.


LA JOLLA, CA—Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United States. The Index, release by the healthcare innovation ecosystem Cure, measures how effectively U.S. biomedical institutions translate scientific discovery into real-world healthcare solutions and treatments. Scripps Research was also named #1 in the West.

The Index ranks the top 303 academic institutions, selected from more than 6,000 nationwide, and represents all 50 states, the District of Columbia and Puerto Rico. The 243 universities are ranked separately from 60 institutes and centers to reflect differences in their structures and missions.

According to the Index, Scripps Research ranks fourth in Research Capabilities and second in Market Translation, reflecting a strong balance between scientific discovery and translational work. Contributing factors to the ranking include the institute’s drug discovery and development arm, Calibr-Skaggs, as well as faculty-led clinical trials and a Clinical and Translational Science Award. As noted on the Index website, “across all three domains, Scripps [Research] presents the profile of an institute where bench science and applied work advance in close proximity.”

Additional institutions named in 2026 are Mass General Brigham, Mayo Clinic, Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute.

“The Index sets a new standard for measuring translational performance across the U.S. biomedical research ecosystem, one that reflects its real and potential positive impact on patients, the healthcare system and the broader economy,” says Seema Kumar, CEO of Cure, in the organization’s press release. “Unlike traditional metrics, which focus on individual outputs, the Cure Innovation Index evaluates the full set of factors required to move innovation from discovery to early research to clinical and commercial impact.”

For more information, visit the Cure Innovation Index website.

Groundbreaking Science.
Life-changing Medicine.